These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28554490)

  • 1. Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.
    Lee JH; Lee AJ; Dang LH; Pang D; Kisselev S; Krinsky-McHale SJ; Zigman WB; Luchsinger JA; Silverman W; Tycko B; Clark LN; Schupf N
    Neurobiol Aging; 2017 Aug; 56():150-158. PubMed ID: 28554490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.
    Schupf N; Lee A; Park N; Dang LH; Pang D; Yale A; Oh DK; Krinsky-McHale SJ; Jenkins EC; Luchsinger JA; Zigman WB; Silverman W; Tycko B; Kisselev S; Clark L; Lee JH
    Neurobiol Aging; 2015 Oct; 36(10):2907.e1-10. PubMed ID: 26166206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.
    Mok KY; Jones EL; Hanney M; Harold D; Sims R; Williams J; Ballard C; Hardy J
    Neurobiol Aging; 2014 Jun; 35(6):1513.e1-5. PubMed ID: 24462566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
    Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S; Väkevä A; Hiltunen M; Soininen H
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.
    Finckh U; von der Kammer H; Velden J; Michel T; Andresen B; Deng A; Zhang J; Müller-Thomsen T; Zuchowski K; Menzer G; Mann U; Papassotiropoulos A; Heun R; Zurdel J; Holst F; Benussi L; Stoppe G; Reiss J; Miserez AR; Staehelin HB; Rebeck GW; Hyman BT; Binetti G; Hock C; Growdon JH; Nitsch RM
    Arch Neurol; 2000 Nov; 57(11):1579-83. PubMed ID: 11074789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.
    Lee JH; Chulikavit M; Pang D; Zigman WB; Silverman W; Schupf N
    Neurosci Lett; 2007 Sep; 425(2):105-9. PubMed ID: 17826910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earlier onset of Alzheimer's disease in men with Down syndrome.
    Schupf N; Kapell D; Nightingale B; Rodriguez A; Tycko B; Mayeux R
    Neurology; 1998 Apr; 50(4):991-5. PubMed ID: 9566384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population.
    Monastero R; Camarda C; Cefalù AB; Caldarella R; Camarda LK; Noto D; Averna MR; Camarda R
    J Alzheimers Dis; 2005 Aug; 7(4):291-5. PubMed ID: 16131730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.
    Lai F; Kammann E; Rebeck GW; Anderson A; Chen Y; Nixon RA
    Neurology; 1999 Jul; 53(2):331-6. PubMed ID: 10430422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
    Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia.
    Lin C; Wang ST; Wu CW; Chuo LJ; Kuo YM
    Chin J Physiol; 2003 Sep; 46(3):111-5. PubMed ID: 14672279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
    Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer's disease in Korean: A case-control study.
    Mun MJ; Kim JH; Choi JY; Kim MS; Jang WC; Lee JJ; Eun YL; Kwak SJ; Kim KW; Lee SB
    J Neurol Sci; 2016 May; 364():122-7. PubMed ID: 27084229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
    Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
    Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    Doran E; Keator D; Head E; Phelan MJ; Kim R; Totoiu M; Barrio JR; Small GW; Potkin SG; Lott IT
    J Alzheimers Dis; 2017; 56(2):459-470. PubMed ID: 27983553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.